Apollo Endosurgery Inc (APEN) Stock
APEN is no longer traded. Apollo Endosurgery was delisted from the Nasdaq in April 2023.
Prices on this page are historical; the last trade was April 3, 2023 at $10.00.
Apollo Endosurgery stock price history
APEN final trading statistics
- Final close
- $10.00
- Final trading day
- Apr 3, 2023
- Market cap at delisting
- $475.49M
- Shares outstanding
- 47.55M
- Final 52-week range
- $3.49 – $10.30
- Avg. volume (final 3 mo.)
- 1,472,849
- All-time high (split-adj.)
- $273.81 · Nov 2007
- All-time low (split-adj.)
- $1.27 · Mar 2020
- Return since IPO
- -91.6%
- Beta
- 2.32
- Book value / share
- $0.78
- Price / book
- 12.89
Apollo Endosurgery annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2022 | $76.86M | -$39.8M | -$0.98 |
| FY2021 | $62.99M | -$24.7M | -$0.89 |
| FY2020 | $42.05M | -$22.6M | -$1.04 |
| FY2019 | $50.71M | -$27.4M | -$1.52 |
| FY2018 | $60.85M | -$45.8M | -$1.93 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Apollo Endosurgery Inc
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices for gastrointestinal therapeutic endoscopy. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to suture and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, and delays gastric content emptying, which assists the patient in losing weight under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands. In addition, the company offers X-Tack Endoscopic HeliX Tacking System, a suture-based device for closing and healing defects in the lower and upper gastrointestinal tract. The company sells its products to medical service providers, hospitals, outpatient surgical centers, clinics, and physicians in the United States, Costa Rica, Australia, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.
Apollo Endosurgery stock FAQ
What happened to Apollo Endosurgery stock?
Apollo Endosurgery stock was delisted from the Nasdaq. Its final close was $10.00 on April 3, 2023.
Is APEN stock still trading?
No. APEN was delisted from the Nasdaq in April 2023 and no longer trades on a U.S. exchange.
What was the last price of APEN stock?
APEN closed at $10.00 on its final trading day, April 3, 2023, for a market value of about $475.49M.
What were Apollo Endosurgery's revenue and earnings in its last full fiscal year?
Apollo Endosurgery reported revenue of $76.86M and net income of -$39.8M in fiscal 2022, its last full year as a public company.
When did Apollo Endosurgery go public?
Apollo Endosurgery Inc stock began trading on December 9, 2005.